156 related articles for article (PubMed ID: 37098835)
1. Ubiquitin ligase MARCH8 promotes the malignant progression of hepatocellular carcinoma through PTEN ubiquitination and degradation.
Xu Y; Zhang D; Ji J; Zhang L
Mol Carcinog; 2023 Jul; 62(7):1062-1072. PubMed ID: 37098835
[TBL] [Abstract][Full Text] [Related]
2. Up-Regulation of Phosphatase in Regenerating Liver-3 (PRL-3) Contributes to Malignant Progression of Hepatocellular Carcinoma by Activating Phosphatase and Tensin Homolog Deleted on Chromosome Ten (PTEN)/Phosphoinositide 3-Kinase (PI3K)/AKT Signaling Pathway.
Li BH; Wang Y; Wang CY; Zhao MJ; Deng T; Ren XQ
Med Sci Monit; 2018 Nov; 24():8105-8114. PubMed ID: 30418964
[TBL] [Abstract][Full Text] [Related]
3. PTEN inhibits the migration and invasion of HepG2 cells by coordinately decreasing MMP expression via the PI3K/Akt pathway.
Tian T; Nan KJ; Guo H; Wang WJ; Ruan ZP; Wang SH; Liang X; Lu CX
Oncol Rep; 2010 Jun; 23(6):1593-600. PubMed ID: 20428814
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol inhibits the malignant progression of hepatocellular carcinoma via MARCH1-induced regulation of PTEN/AKT signaling.
Dai H; Li M; Yang W; Sun X; Wang P; Wang X; Su J; Wang X; Hu X; Zhao M
Aging (Albany NY); 2020 Jun; 12(12):11717-11731. PubMed ID: 32530437
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
[TBL] [Abstract][Full Text] [Related]
6. Targeted inhibition of ACK1 can inhibit the proliferation of hepatocellular carcinoma cells through the PTEN/AKT/mTOR pathway.
Wang B; Song K; Chen L; Su H; Gao L; Liu J; Huang A
Cell Biochem Funct; 2020 Jul; 38(5):642-650. PubMed ID: 32162707
[TBL] [Abstract][Full Text] [Related]
7. Down-regulated lncRNA TP73-AS1 reduces radioresistance in hepatocellular carcinoma via the PTEN/Akt signaling pathway.
Song W; Zhang J; Xia Q; Sun M
Cell Cycle; 2019 Nov; 18(22):3177-3188. PubMed ID: 31564201
[No Abstract] [Full Text] [Related]
8. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
[TBL] [Abstract][Full Text] [Related]
9. IMP3 accelerates the progression of prostate cancer through inhibiting PTEN expression in a SMURF1-dependent way.
Zhang X; Wang D; Liu B; Jin X; Wang X; Pan J; Tu W; Shao Y
J Exp Clin Cancer Res; 2020 Sep; 39(1):190. PubMed ID: 32938489
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA Linc01296 promotes hepatocellular carcinoma development through regulation of the miR-26a/PTEN axis.
Zhang L; Hu J; Hao M; Bu L
Biol Chem; 2020 Feb; 401(3):407-416. PubMed ID: 31318685
[TBL] [Abstract][Full Text] [Related]
11. Hsa_circ_0007059 sponges miR-421 to repress cell growth and stemness in hepatocellular carcinoma by the PTEN-AKT/mTOR pathway.
Hui Y; Jin D; Leng J; Liu D; Yuan P; Tang C; Wang Q
Pathol Res Pract; 2022 Jan; 229():153692. PubMed ID: 34847369
[TBL] [Abstract][Full Text] [Related]
12. Long non‑coding RNA Fer‑1‑like family member 4 suppresses hepatocellular carcinoma cell proliferation by regulating PTEN in vitro and in vivo.
Sun X; Zheng G; Li C; Liu C
Mol Med Rep; 2019 Jan; 19(1):685-692. PubMed ID: 30431133
[TBL] [Abstract][Full Text] [Related]
13. Lentinan induces apoptosis of mouse hepatocellular carcinoma cells through the EGR1/PTEN/AKT signaling axis.
You J; Wu Q; Li Y; Li X; Lin Z; Huang J; Xue Y; Gulimiran A; Pan Y
Oncol Rep; 2023 Jul; 50(1):. PubMed ID: 37264970
[TBL] [Abstract][Full Text] [Related]
14. METTL1 overexpression is correlated with poor prognosis and promotes hepatocellular carcinoma via PTEN.
Tian QH; Zhang MF; Zeng JS; Luo RG; Wen Y; Chen J; Gan LG; Xiong JP
J Mol Med (Berl); 2019 Nov; 97(11):1535-1545. PubMed ID: 31463732
[TBL] [Abstract][Full Text] [Related]
15. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
[TBL] [Abstract][Full Text] [Related]
16. HRD1-mediated PTEN degradation promotes cell proliferation and hepatocellular carcinoma progression.
Liu L; Long H; Wu Y; Li H; Dong L; Zhong JL; Liu Z; Yang X; Dai X; Shi L; Ren M; Lin Z
Cell Signal; 2018 Oct; 50():90-99. PubMed ID: 29958993
[TBL] [Abstract][Full Text] [Related]
17. AEG-1/miR-221 Axis Cooperatively Regulates the Progression of Hepatocellular Carcinoma by Targeting PTEN/PI3K/AKT Signaling Pathway.
Kannan M; Jayamohan S; Moorthy RK; Chabattula SC; Ganeshan M; Arockiam AJV
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31698701
[TBL] [Abstract][Full Text] [Related]
18. Rap2B knockdown suppresses malignant progression of hepatocellular carcinoma by inactivating the PTEN/PI3K/Akt and ERK1/2 pathways.
Zhu L; Sun Y; Zhang S; Wang L
Mol Cell Biochem; 2020 Mar; 466(1-2):55-63. PubMed ID: 32052247
[TBL] [Abstract][Full Text] [Related]
19. NEDD4 Depletion Inhibits Hepatocellular Carcinoma Growth via Targeting PTEN.
Hang X; Zhu S; Di H; Wu Z; Chu K; Wang J; Xin H; Yu G; Peng H; Miao X; Xu W
Cell Physiol Biochem; 2016; 39(2):768-79. PubMed ID: 27467187
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the GNMT-HectH9-PREX2 tripartite relationship in the pathogenesis of hepatocellular carcinoma.
Li CH; Yen CH; Chen YF; Lee KJ; Fang CC; Zhang X; Lai CC; Huang SF; Lin HK; Arthur Chen YM
Int J Cancer; 2017 May; 140(10):2284-2297. PubMed ID: 28205209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
